Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Receivables - Net (2021)

Historic Receivables - Net for Vistagen Therapeutics (VTGN) over the last 3 years, with Q1 2021 value amounting to $40600.0.

  • Vistagen Therapeutics' Receivables - Net changed N/A to $40600.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $40600.0, marking a year-over-year change of. This contributed to the annual value of $40600.0 for FY2021, which is N/A changed from last year.
  • Vistagen Therapeutics' Receivables - Net amounted to $40600.0 in Q1 2021.
  • Vistagen Therapeutics' Receivables - Net's 5-year high stood at $40600.0 during Q1 2021, with a 5-year trough of $40600.0 in Q1 2021.